Site Search

A number of IMI’s projects are making valuable contributions to the global effort to tackle COVID-19. The contributions include knowledge, tools and expertise, and while some come from projects in the infectious disease field, projects working in other areas, such as data ...

Proximity to their customer base means SMEs can fine-tune their products and spot new applications for them. It also helps with the regulatory process

KRONO’s COVID-19 test technology will make the world more prepared for new threats to human, animal and even plant health

IMI has enticed over 300 SMEs to join our research efforts, despite legitimate concerns about IP and consortia size

The INNODIA project is launching four diabetes drug studies, designed according to their regulator-approved master protocol

The Hypo-RESOLVE project is studying data to single out the risk factors for severe hypoglycaemic episodes